Ex vivo gene therapy for GM1-gangliosidosis

Project Information

GT-GM1

Grant agreement ID: 843569

DOI 10.3030/843569

Project closed

EC signature date 2 April 2019

Start date 1 September 2020

End date 31 August 2022

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 171 473,28

EU contribution € 171 473,28

Coordinated by

UNIVERSITA DEGLI STUDI DI PADOVA
Italy

Publications

Conference proceedings (2)

Development of an Ex Vivo Gene Therapy for Infantile GM1-Gangliosidosis

Author(s): Linda Bucciarelli, Rita Milazzo, Alessandra Biffi, Valentina Poletti
Published in: Molecular Therapy, 2022 ASGCT Annual Meeting Abstracts, Issue Molecular Therapy, Volume 30, Issue 4, Supplement 1, 2 May 2022, Pages 1-592, 2022, Page(s) 1-592
Publisher: Elsevier
DOI: 10.1016/j.ymthe.2022.04.017

Development of an ex vivo Gene Therapy for Infantile GM1-Gangliosidosis

Author(s): Linda Bucciarelli, Rita Milazzo, Alessandra Biffi, Valentina Poletti
Published in: Human Gene Therapy, Issue Volume: 32 Issue 19-20: October 18, 2021, 2021, Page(s) A1-A152
Publisher: Mary Ann Liebert, Inc.
DOI: 10.1089/hum.2021.29180.abstracts